CN1809350A - 抑郁症和其他情感障碍的治疗 - Google Patents
抑郁症和其他情感障碍的治疗 Download PDFInfo
- Publication number
- CN1809350A CN1809350A CNA2004800175886A CN200480017588A CN1809350A CN 1809350 A CN1809350 A CN 1809350A CN A2004800175886 A CNA2004800175886 A CN A2004800175886A CN 200480017588 A CN200480017588 A CN 200480017588A CN 1809350 A CN1809350 A CN 1809350A
- Authority
- CN
- China
- Prior art keywords
- gaboxadol
- hydroxy tryptamine
- reuptake inhibitor
- pharmaceutical composition
- described application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200300956 | 2003-06-25 | ||
DKPA200300956 | 2003-06-25 | ||
DKPA200400016 | 2004-01-07 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007101801789A Division CN101156850A (zh) | 2003-06-25 | 2004-06-25 | 抑郁症和其他情感障碍的治疗 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1809350A true CN1809350A (zh) | 2006-07-26 |
Family
ID=36701616
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007101801789A Pending CN101156850A (zh) | 2003-06-25 | 2004-06-25 | 抑郁症和其他情感障碍的治疗 |
CNA2004800175886A Pending CN1809350A (zh) | 2003-06-25 | 2004-06-25 | 抑郁症和其他情感障碍的治疗 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007101801789A Pending CN101156850A (zh) | 2003-06-25 | 2004-06-25 | 抑郁症和其他情感障碍的治疗 |
Country Status (4)
Country | Link |
---|---|
CN (2) | CN101156850A (ru) |
CL (1) | CL2004001603A1 (ru) |
UA (1) | UA90656C2 (ru) |
ZA (1) | ZA200509356B (ru) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105816457A (zh) * | 2016-05-30 | 2016-08-03 | 杨强 | 含有盐酸帕罗西汀的药物组合物及其用途 |
CN110996910A (zh) * | 2017-05-24 | 2020-04-10 | 奥维德医疗公司 | 抑郁障碍的治疗 |
CN113395962A (zh) * | 2018-11-21 | 2021-09-14 | Certego治疗公司 | 加波沙朵用于降低自杀风险和快速缓解抑郁症 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3761979A4 (en) * | 2018-04-06 | 2021-06-30 | Ovid Therapeutics Inc. | USE OF GABOXADOL TO TREAT SUBSTANCE ABUSE |
KR20230028244A (ko) | 2020-05-20 | 2023-02-28 | 썰테고 테라퓨틱스 아이엔씨. | 고리 중수소화 가복사돌 및 정신 장애의 치료를 위한 이의 용도 |
-
2004
- 2004-06-24 CL CL200401603A patent/CL2004001603A1/es unknown
- 2004-06-25 CN CNA2007101801789A patent/CN101156850A/zh active Pending
- 2004-06-25 CN CNA2004800175886A patent/CN1809350A/zh active Pending
- 2004-06-25 UA UAA200600374A patent/UA90656C2/ru unknown
- 2004-06-25 ZA ZA200509356A patent/ZA200509356B/en unknown
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105816457A (zh) * | 2016-05-30 | 2016-08-03 | 杨强 | 含有盐酸帕罗西汀的药物组合物及其用途 |
CN110996910A (zh) * | 2017-05-24 | 2020-04-10 | 奥维德医疗公司 | 抑郁障碍的治疗 |
CN113395962A (zh) * | 2018-11-21 | 2021-09-14 | Certego治疗公司 | 加波沙朵用于降低自杀风险和快速缓解抑郁症 |
Also Published As
Publication number | Publication date |
---|---|
CN101156850A (zh) | 2008-04-09 |
ZA200509356B (en) | 2007-03-28 |
UA90656C2 (ru) | 2010-05-25 |
CL2004001603A1 (es) | 2005-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101448805B (zh) | 抑郁障碍的治疗 | |
US20090203731A1 (en) | Treatment of depression and other affective disorders | |
US20100267772A1 (en) | Combination of a Serotonin Reuptake Inhibitor and Agomelatine | |
JP2007508236A (ja) | うつ病およびその他の情動障害を治療する方法 | |
CN1674880A (zh) | 用于治疗体温调节机能障碍的5HT2a受体的激动作用 | |
CA2813648A1 (en) | Combinations of serotonin receptor agonists for treatment of movement disorders | |
CN104955483A (zh) | 用低剂量药剂治疗抑郁症和其它疾病 | |
CN1809350A (zh) | 抑郁症和其他情感障碍的治疗 | |
CN1292749C (zh) | 2-[5-(4-氟苯基)-3-吡啶基甲氨基甲基]苯并二氢吡喃及其生理学上可接受的盐的新用途 | |
MXPA04012693A (es) | Terapia de combinacion en donde se utiliza un inhibidor de recaptacion de serotonina. | |
AU2004269858A1 (en) | The combination of a serotonin reuptake inhibitor and Loxapine | |
PIĄTKOWSKA-CHMIEL et al. | THE ANALGESIC EFFECT OF 1, 3-THIAZOLIDIN-4-ONE DERIVATIVES AS POTENTIAL MODULATORS OF THE SEROTONINERGIC SYSTEM. | |
US20070042014A1 (en) | Combination of a serotonin reuptake inhibitor and loxapine | |
US20060223857A1 (en) | Combination of a serotonin reuptake inhibitor and a glycine transporter type 1 inhibitor for the treatment of depression | |
CA2529805A1 (en) | Gaboxadol for treating depression and other affective disorders | |
US20070066601A1 (en) | Combination of a serotonin reuptake inhibitor and a histamine 3 receptor antagonist, inverse agonist or partial agonist | |
JP2007513896A (ja) | セロトニン再取り込み阻害剤およびヒスタミン3受容体アンタゴニスト、インバースアゴニストまたはパーシャルアゴニストの併用 | |
US20080167290A1 (en) | Combination of a Serotonin Reuptake Inhibitor and Amoxapine | |
CA2537757A1 (en) | The combination of a serotonin reuptake inhibitor and amoxapine | |
MXPA06005127A (en) | The combination of a serotonin reuptake inhibitor and a histamine 3 receptor antagonist, inverse agonist or partial agonist |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1092058 Country of ref document: HK |
|
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Open date: 20060726 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1092058 Country of ref document: HK |